Affimed N.V. (AFMD) announced that it has appointed Shawn M. Leland as the company’s new chief executive officer (CEO). Shares of the company were down 6.6% on Sep 3 following the announcement of the news.Leland will replace Andreas Harstrick who has been the acting CEO of Affimed since January 2024. The latter will continue in his role as the chief medical officer.Leland most recently served as the interim CEO and board director of ForeBio. Previously, he held various senior leadership positions at Veraste ...